These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173 [TBL] [Abstract][Full Text] [Related]
6. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice. Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178 [TBL] [Abstract][Full Text] [Related]
7. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1. Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435 [TBL] [Abstract][Full Text] [Related]
8. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. Zhang S; Chung WC; Xu K Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302 [TBL] [Abstract][Full Text] [Related]
9. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Giannuzzo A; Pedersen SF; Novak I Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222 [TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
11. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
13. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047 [TBL] [Abstract][Full Text] [Related]
14. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
15. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Shen J; Ha DP; Zhu G; Rangel DF; Kobielak A; Gill PS; Groshen S; Dubeau L; Lee AS Proc Natl Acad Sci U S A; 2017 May; 114(20):E4020-E4029. PubMed ID: 28461470 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Rooman I; Real FX Gut; 2012 Mar; 61(3):449-58. PubMed ID: 21730103 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859 [TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
19. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment. Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995 [TBL] [Abstract][Full Text] [Related]
20. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer. Rawnaq T; Dietrich L; Wolters-Eisfeld G; Uzunoglu FG; Vashist YK; Bachmann K; Simon R; Izbicki JR; Bockhorn M; Güngör C Mol Cancer Res; 2014 May; 12(5):670-80. PubMed ID: 24567526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]